Payment overview · 2025
General Payments
$48.61
2 reported records · 2 companies
Healthcare provider profile · identity verified
Patrick J Mcmanus, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · FREDERICKSBURG, VA · NPI 1558360735
Verified facts
What the public records show
CMS Open Payments records show Patrick J Mcmanus, M.D. received $48.61 in general payments during 2025 across 2 reported records.
MAYNE PHARMA COMMERCIAL LLC accounted for 54.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | Unresolved — no canonical attribution shown | $26.25 | 54.0% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $22.36 | 46.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $48.61 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $22.36 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 429 | 127 |
| Levothyroxine Sodium | Levothyroxine Sodium | 366 | 97 |
| Omeprazole | Omeprazole | 358 | 102 |
| Metoprolol Succinate | Metoprolol Succinate | 302 | 89 |
| Amlodipine Besylate | Amlodipine Besylate | 271 | 78 |
| Eliquis | Apixaban | 258 | 53 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 256 | 90 |
| Losartan Potassium | Losartan Potassium | 236 | 70 |
| Prednisone | Prednisone | 225 | 100 |
| Spironolactone | Spironolactone | 177 | 50 |
| Gabapentin | Gabapentin | 168 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 161 | 49 |
| Lisinopril | Lisinopril | 152 | 52 |
| Simvastatin | Simvastatin | 133 | 37 |
| Pantoprazole Sodium | Pantoprazole Sodium | 130 | 38 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 127 | 34 |
| Ezetimibe | Ezetimibe | 126 | 40 |
| Carvedilol | Carvedilol | 120 | 29 |
| Quetiapine Fumarate | Quetiapine Fumarate | 118 | 32 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 117 | 34 |
| Metformin Hcl Er | Metformin Hcl | 112 | 36 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 100 | 20 |
| Metformin Hcl | Metformin Hcl | 99 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 98 | 25 |
| Irbesartan | Irbesartan | 96 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 94 | 27 |
| Potassium Chloride | Potassium Chloride | 94 | 26 |
| Montelukast Sodium | Montelukast Sodium | 92 | 27 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 91 | 19 |
| Famotidine | Famotidine | 85 | 24 |
| Doxycycline Hyclate | Doxycycline Hyclate | 84 | 55 |
| Hydrochlorothiazide | Hydrochlorothiazide | 79 | 22 |
| Allopurinol | Allopurinol | 76 | 25 |
| Amoxicillin | Amoxicillin | 74 | 55 |
| Furosemide | Furosemide | 72 | 26 |
| Tizanidine Hcl | Tizanidine Hcl | 72 | 30 |
| Ramipril | Ramipril | 70 | 22 |
| Tramadol Hcl | Tramadol Hcl | 70 | 15 |
| Glimepiride | Glimepiride | 66 | 22 |
| Torsemide | Torsemide | 66 | 15 |
| Zolpidem Tartrate | Zolpidem Tartrate | 65 | 19 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 61 | 39 |
| Meloxicam | Meloxicam | 61 | 16 |
| Trazodone Hcl | Trazodone Hcl | 61 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 60 | 18 |
| Synthroid | Levothyroxine Sodium | 56 | 18 |
| Alprazolam | Alprazolam | 52 | 12 |
| Myrbetriq | Mirabegron | 52 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 52 | 32 |
| Azithromycin | Azithromycin | 51 | 43 |
| Warfarin Sodium | Warfarin Sodium | 51 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 50 | 15 |
| Memantine Hcl | Memantine Hcl | 47 | 11 |
| Lorazepam | Lorazepam | 45 | 21 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 44 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 44 | 20 |
| Jardiance | Empagliflozin | 44 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 44 | 12 |
| Nebivolol Hcl | Nebivolol Hcl | 44 | 13 |
| Valsartan | Valsartan | 44 | 13 |
| Paxlovid | Nirmatrelvir/Ritonavir | 43 | 40 |
| Bupropion Xl | Bupropion Hcl | 42 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 41 | suppressed |
| Trulicity | Dulaglutide | 41 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 40 | 14 |
| Mirtazapine | Mirtazapine | 38 | 12 |
| Sertraline Hcl | Sertraline Hcl | 38 | 13 |
| Colchicine | Colchicine | 37 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 36 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 35 | suppressed |
| Estradiol | Estradiol | 35 | suppressed |
| Chlorthalidone | Chlorthalidone | 33 | 11 |
| Finasteride | Finasteride | 33 | 12 |
| Raloxifene Hcl | Raloxifene Hcl | 33 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 32 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 32 | suppressed |
| Ozempic | Semaglutide | 32 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 31 | suppressed |
| Celecoxib | Celecoxib | 31 | suppressed |
| Lansoprazole | Lansoprazole | 30 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 29 | 17 |
| Bumetanide | Bumetanide | 29 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 29 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 29 | suppressed |
| Xarelto | Rivaroxaban | 29 | suppressed |
| Pregabalin | Pregabalin | 27 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 27 | suppressed |
| Acyclovir | Acyclovir | 26 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 26 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 26 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Atenolol | Atenolol | 24 | suppressed |
| Januvia | Sitagliptin Phosphate | 24 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 24 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 24 | suppressed |
| Febuxostat | Febuxostat | 23 | suppressed |
| Calcitriol | Calcitriol | 22 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 22 | 14 |
| Nystatin | Nystatin | 22 | 11 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Aripiprazole | Aripiprazole | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Fluconazole | Fluconazole | 20 | 14 |
| Ketoconazole | Ketoconazole | 20 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 12 |
| Ciclopirox | Ciclopirox Olamine | 19 | suppressed |
| Methadone Hcl | Methadone Hcl | 19 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 19 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | suppressed |
| Cefdinir | Cefdinir | 18 | 14 |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 17 | suppressed |
| Dutasteride | Dutasteride | 17 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 17 | suppressed |
| Vascepa | Icosapent Ethyl | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 16 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 15 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 15 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 14 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 13 | suppressed |
| Entresto | Sacubitril/Valsartan | 13 | suppressed |
| Jantoven | Warfarin Sodium | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 13 | suppressed |
| Multaq | Dronedarone Hcl | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 13 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Eplerenone | Eplerenone | 12 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 12 | suppressed |
| Humalog | Insulin Lispro | 12 | suppressed |
| Klor-Con 10 | Potassium Chloride | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 12 | suppressed |
| Baclofen | Baclofen | 11 | suppressed |
| Cephalexin | Cephalexin | 11 | suppressed |
| Digoxin | Digoxin | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 11 | 11 |
| Repatha Sureclick | Evolocumab | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $48.61 · 2 records | MAYNE PHARMA COMMERCIAL LLC | FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error